Melanoma

MELANOMA NEWS TIPS & FEATURES

Choosing Stronger Sunscreen Would Reduce Women's Melanoma Risk

November 8th, 2016

Choosing Stronger Sunscreen Would Reduce Women’s Melanoma Risk

Doctors estimate that the number of women affected by the deadliest form of skin cancer could be reduced by almost 20% if all women used […]


Yervoy® Improves Overall Survival in Fully Resected Stage III Melanoma Patients

October 24th, 2016

Yervoy® Improves Overall Survival in Fully Resected Stage III Melanoma Patients

Results were presented during the 2016 European Society for Medical Oncology Congress demonstrating that Yervoy® (ipilimumab) compared to placebo improves survival in stage III melanoma […]


Epacadostat Plus Keytruda® Appears Effective in Melanoma

October 11th, 2016

Epacadostat Plus Keytruda® Appears Effective in Melanoma

The treatment combination consisting of epacadostat plus Keytruda® (pembrolizumab) appears effective in the treatment of advanced melanoma. Melanoma is a type of skin cancer that […]


Cotellic®/Zelboraf® Combo: New Standard of Care for Melanoma

September 20th, 2016

Cotellic®/Zelboraf® Combo: New Standard of Care for Melanoma

The treatment combination consisting of Cotellic® (cobimetinib) plus Zelboraf® (vemurafenib) improves overall survival for patients with advanced, BRAF (V600) mutation-positive melanoma. These confirmatory results have […]


3-Year Survival Improved with Taflinar®/Mekinist® Combination in Advanced Melanoma

July 21st, 2016

3-Year Survival Improved with Taflinar®/Mekinist® Combination in Advanced Melanoma

Patients with advanced melanoma who were treated with the combination consisting of Taflinar (dabrafenib) plus Mekinist (trametinib) had a significantly improved survival rate at 3 […]


Counsyl Announces Major Oncology Expansion to Advance Genetic Screening for Cancer Risk

May 25th, 2016

Counsyl Announces Major Oncology Expansion to Advance Genetic Screening for Cancer Risk

Counsyl launches oncology business unit, an expanded test to assess risk for inherited forms of cancer, and tools to improve genetic screening rates across the […]


Check It Out: May is Skin Cancer Awareness Month

May 3rd, 2016

Check It Out: May is Skin Cancer Awareness Month

Skin cancer is the most commonly diagnosed cancer in the United States. Although the majority of skin cancers fall under basal cell and squamous cell […]


NLN Update on the Lymphedema Treatment Act

March 22nd, 2016

NLN Update on the Lymphedema Treatment Act

Updated March 2016 2016 may well be the year that Congress votes to approve the Lymphedema Treatment Act, which provides a Medicare benefit category for […]


Year in Review:  Melanoma

February 24th, 2016

Year in Review: Melanoma

After several years of exciting developments in melanoma therapy, progress continued throughout 2015 with FDA approved PD-1 immunotherapy treatments and the first-ever approved oncolytic virus […]


Patients With Early-Stage Melanoma And Lung Cancer Among Those Standing To Benefit From Immunotherapy

January 29th, 2016

Patients With Early-Stage Melanoma And Lung Cancer Among Those Standing To Benefit From Immunotherapy

Excerpted from: Advances in Cancer Research And Treatment: 2015 Year In Review Immunotherapy, a type of biological therapy, is among the most promising areas of […]


More News →